Work

Comment, et pour qui, évaluer la valeur thérapeutique ajoutée d'un nouveau médicament ?

Year: 2011

Type: article

Author: Intervention de Beate Wieseler

Language: French

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2464139399

FWCI:

Cites: 6

Cited by:

Related to: 10